Want to hire this expert for a project? Request a quote for free.
Profile Details
Subject Matter Expertise
Services
Work Experience
Safety Reporting Administrator
Pharmaceutical Product Development Inc
July 2017 - Present
Freelance translator Spanish-English
Cactus Communications Inc
March 2017 - Present
Clinical Research Associate
Pharmaceutical Product Development Inc
July 2019 - July 2021
Freelance editor
Enago
March 2017 - July 2017
Clinical Research Fellow
University of North Carolina at Chapel Hill
October 2016 - June 2017
Clinical Research Fellow
University of North Carolina Hospitals
August 2016 - October 2016
Regulatory Affairs Intern
Chiesi Pharmaceuticals Inc
August 2016 - October 2016
Post-doctoral Research Associate Fellow
North Carolina State University
August 2014 - July 2016
Post-doctoral Research Fellow
Wake Forest School of Medicine
February 2011 - July 2014
Graduate Research Assistant
University of Nevada Reno
February 2006 - December 2010
Education
Medical Product Safety and Pharmacovigilance Certificate
Durham Technical Community College
2017 - Present
Data Management Certificate
Durham Technical Community College
2017 - Present
Ph.D in Cellular and Molecular Biology
University of Nevada Reno
January 2006 - December 2010
Licenciatura en Biotecnologia (Equivalent to a Master In Biotechnology)
Universidad Nacional de Rosario Facultad de Ciencias Bioquimicas y Farmaceuticas
March 1996 - April 2005
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., et al.(2016). AAV Gene Therapy for MPS1-associated Corneal Blindness . Scientific Reports. 6.
(2014). Evaluation of gene delivery strategies to efficiently over-express functional hla-G on human bone marrow stromal cells. Molecular Therapy.
(2014). Perivascular stromal cells as a potential reservoir of human cytomegalovirus . American Journal of Transplantation. 14. (4). p. 820-830.
Soland, M.A., Bego, M., Colletti, E., Zanjani, E.D., St. Jeor, S., Porada, C.D., Almeida-Porada, G.(2013). Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage . PLoS ONE. 8. (3).
Almeida-Porada, G., Soland, M., Boura, J., Porada, C.D.(2013). Regenerative medicine: Prospects for the treatment of inflammatory bowel disease . Regenerative Medicine. 8. (5). p. 631-644.
(2013). Mesenchymal stem cells contribute to endogenous FVIII: C production . Journal of Cellular Physiology. 228. (5). p. 1010-1016.
(2013). EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool . FASEB Journal. 27. (6). p. 2111-2121.
(2012). HCMV Protein LUNA Is Required for Viral Reactivation from Latently Infected Primary CD14<sup>+</sup>Cells . PLoS ONE. 7. (12).
(2012). Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation . Journal of General Virology. 93. (4). p. 722-732.
(2012). Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus US proteins . PLoS ONE. 7. (5).
Soland, M.(2011). Modulation of mesenchymal stem cell immunogenicity through stable expression of human cytomegalovirus proteins . Rejuvenation Research. 14. (3). p. 342-343.
BOOK CHAPTER
(2015). AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic . Gene Therapy Principles and Challenges.